← Back to Search

Reverberation Impact on Spatial Hearing Development

Q: How many individuals have enrolled in this research project?

Yes, the data on clinicaltrials.gov indicates that this experiment is in the process of enrolling patients. Initially posted on July 1st 2022 and recently updated April 4th 2023, it requires 120 volunteers from one distinct medical facility.

Q: Is the age restriction for this medical study limited to those over 45 years old?

As dictated by the eligibility requirements, only individuals aged between 6 and 30 are eligible to enroll in this clinical trial.

Q: Is there currently an opportunity for participants to enroll in the study?

According to clinicaltrials.gov, this research endeavour is currently recruiting participants. This trial was initially uploaded on July 1st 2022 and has been recently updated as of April 4th 2023.

Q: What criteria must be met for someone to qualify as a participant in this trial?

Subjects wishing to join this trial must possess spatial auditory faculties and be between the ages of 6-30. This research is currently seeking 120 participants.

Phase < 1

Recruiting

Led By Z. Ellen Peng

Research Sponsored by Father Flanagan's Boys' Home

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 1-3

Awards & highlights

Study Summary

This trial study looks at how hearing abilities develop in kids ages 6-18, & how they hear objects in reverberant vs non-reverberant environments. Researchers compare kids' responses to adult responses to measure development.

Who is the study for?

This trial is for typically developing children aged 6-18 with normal hearing, able to hear sounds at a soft level across a range of pitches. It excludes those who don't pass the hearing test or have intellectual developmental disabilities.Check my eligibility

What is being tested?

The study examines how kids develop the ability to hear in places with echo (reverberation). They'll do listening tasks in virtual rooms designed to have no echo or different levels of it, similar to real indoor spaces.See study design

What are the potential side effects?

Since this trial involves only listening tasks in controlled environments, there are no direct medical side effects. However, participants may experience fatigue or discomfort from wearing headphones during the tests.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 1-3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 1-3

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 1-3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Auditory Object Size (Apparent Source Width)

Spatial Acuity (Minimum audible angle)

Spatial Unmasking (Minimum angular separation)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Low-ReverberationExperimental Treatment1 Intervention

Participants perform psychoacoustic tasks under a low-reverberant environment and a control environment without reverberation.

Group II: High-ReverberationExperimental Treatment1 Intervention

Participants perform psychoacoustic tasks under a high-reverberant environment and a control environment without reverberation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Father Flanagan's Boys' HomeLead Sponsor

10 Previous Clinical Trials

1,008 Total Patients Enrolled

Z. Ellen PengPrincipal InvestigatorFather Flanagan's Boys' Home

Media Library

High-Reverberation Clinical Trial Eligibility Overview. Trial Name: NCT05815537 — Phase < 1

Spatial Hearing Development Research Study Groups: High-Reverberation, Low-Reverberation

Spatial Hearing Development Clinical Trial 2023: High-Reverberation Highlights & Side Effects. Trial Name: NCT05815537 — Phase < 1

High-Reverberation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05815537 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have enrolled in this research project?

"Yes, the data on clinicaltrials.gov indicates that this experiment is in the process of enrolling patients. Initially posted on July 1st 2022 and recently updated April 4th 2023, it requires 120 volunteers from one distinct medical facility."

Answered by AI

Is the age restriction for this medical study limited to those over 45 years old?

"As dictated by the eligibility requirements, only individuals aged between 6 and 30 are eligible to enroll in this clinical trial."

Answered by AI

Is there currently an opportunity for participants to enroll in the study?

"According to clinicaltrials.gov, this research endeavour is currently recruiting participants. This trial was initially uploaded on July 1st 2022 and has been recently updated as of April 4th 2023."

Answered by AI

What criteria must be met for someone to qualify as a participant in this trial?

"Subjects wishing to join this trial must possess spatial auditory faculties and be between the ages of 6-30. This research is currently seeking 120 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Development of Functional Spatial Hearing in Reverberation

Ellen Peng 2024. "Development of Functional Spatial Hearing in Reverberation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05815537.